Endothelial Progenitor Cell Therapy for Atherosclerosis: The Philosopher's Stone for an Aging Population?
- 22 June 2005
- journal article
- perspectives
- Published by American Association for the Advancement of Science (AAAS) in Science of Aging Knowledge Environment
- Vol. 2005 (25) , pe18
Abstract
Much of the increased risk for atherosclerosis progression with age may be a result of age-related declines in the capacity of precursor cells to repair damage in the arterial endothelium. To estimate the impact of progenitor cell therapy for atherosclerosis on cardiovascular disease (CVD) mortality, life expectancy, and survival, as compared with the lifetime control of conventional risk factors, we modeled the health effects of bone marrow-derived endothelial progenitor cell therapy using data from the 1950 to 1996 follow-up of the Framingham Heart Study. To model cardiovascular disease mortality, we assumed that progenitor cell therapy was applied at age 30, with the effect assumed to be a 10-year delay in atherosclerosis progression. Age projections were constructed analytically using the stochastic process model for risk factor dynamics and mortality and microsimulation techniques. We considered three types of interventions: (i) keeping risk factors within selected limits to model current clinical recommendations; (ii) an age shift of 10 years to model the effects of progenitor cell therapy; and (iii) elimination of a competing risk (such as cancer). Our study suggests that progenitor cell therapy might increase life expectancy in the population as much as the complete elimination of cancer (in females, an additional 3.67 versus 3.37 years; in males, an additional 5.94 versus 2.86 years, respectively).Keywords
This publication has 18 references indexed in Scilit:
- Life Tables with Covariates: Dynamic Model for Nonlinear Analysis of Longitudinal DataMathematical Population Studies, 2005
- Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemiaClinical Science, 2004
- Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima FormationCirculation, 2003
- White Cell Telomere Length and Risk of Premature Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Prevention of Cardiovascular Risk Factors in the First PlacePreventive Medicine, 1999
- Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.Journal of Clinical Investigation, 1995
- J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosisThe Lancet, 1994
- Risk Factor Dynamics, Mortality and Life Expectancy Differences between Eastern and Western Finland: The Finnish Cohorts of the Seven Countries StudyInternational Journal of Epidemiology, 1992
- Longitudinal Models for Chronic Disease Risk: an Evaluation of Logistic Multiple Regression and AlternativesInternational Journal of Epidemiology, 1981